Yingtai Bio is a listed company on the top floor of the New Third Board, and Zhuo Yuan Yi Hui Investment Co., Ltd., a wholly-owned subsidiary of Winbond Health, holds 66.76% of Yingtai Bio's shares. Kaisheng New Materials, a subsidiary of Winbond Health, was split and listed, and Winbond Health is making every effort to promote the selective layered transfer of Yingtai Bio, a subsidiary.